Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

NCT00266097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Pancreatic Cancer

Interventions

DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin
RADIATION: radiation therapy
DRUG: gemcitabine hydrochloride
DRUG: Oxaliplatin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]